Long-term treatment results of Polish pediatric and adolescent patients enrolled in the ALL IC-BFM 2002 trial
- PMID: 31432528
- PMCID: PMC6852109
- DOI: 10.1002/ajh.25619
Long-term treatment results of Polish pediatric and adolescent patients enrolled in the ALL IC-BFM 2002 trial
Conflict of interest statement
The authors declare no potential conflict of interest.
Figures
References
-
- Stary J, Zimmermann M, Campbell M, et al. Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC‐BFM 2002. J Clin Oncol. 2014;32(3):174‐184. - PubMed
-
- Cui L, Li ZG, Chai YH, et al. Outcome of children with newly diagnosed acute lymphoblastic leukemia treated with CCLG‐ALL 2008: The first nation‐wide prospective multicenter study in China. Am J Hematol. 2018;93(7):913‐920. - PubMed
-
- Christensen MS, Heyman M, Mottonen M, et al. Treatment‐related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992‐2001. Br J Haematol. 2005;131(1):50‐58. - PubMed
-
- Moricke A, Zimmermann M, Valsecchi MG, et al. Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP‐BFM ALL 2000. Blood. 2016;127(17):2101‐2112. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources